HC Surgical Specialists : Hcss Joins the Nation’s Efforts in Covid-19 PCR and ART Testing Download PDF

HC SURGICAL SPECIALISTS LIMITED

Incorporated in the Republic of Singapore

Registration No. 201533429G

HCSS JOINS THE NATION'S EFFORTS IN COVID-19 PCR AND ART TESTING

The Board of Directors (the "Board") of HC Surgical Specialists Limited (the "Company" and together with its subsidiaries, the "Group") is pleased to announce that the Ministry of Health has granted a licence to one of the Group's clinics, HC Endoscopy & Piles Centre (Hillford), for the provision of, among others, COVID-19 polymerase chain reaction ("PCR") testing, pre-departureCOVID-19 testing, COVID-19 saliva PCR testing and COVID-19 antigen rapid test ("ART") services (the "COVID-19testing services"), in addition to the Group's existing licenced ACMS Medical Clinic.

The appointed clinics are located at:-

1. HC Endoscopy & Piles Centre (Hillford) 182 Jalan Jurong Kechil
   #01-66 The Hillford Singapore 596152 Tel: [phone]
2. ACMS Medical Clinic 1 Grange Road #06-06 Orchard Building Singapore 239693
   Tel: [phone]

Dr. Heah Sieu Min, Executive Director and Chief Executive Officer of the Company said: "As the nation moves to live with COVID-19 and countries open their borders to travellers, COVID-19 testing services have become the norm. As fellow healthcare workers, we wish to do our part to help people with their testing needs."

By Order of the Board

Dr. Heah Sieu Min

Executive Director and Chief Executive Officer

16 February 2022

About HC Surgical Specialists Limited

HC Surgical Specialists Limited (the "Company") was incorporated on 1 September 2015 in Singapore and listed on Catalist of the Singapore Exchange Securities Trading Limited on 3 November 2016. The Company, its subsidiaries and associated company are a medical services group primarily engaged in the provision of endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services with a focus on colorectal procedures across a network of 16 clinics located throughout Singapore.

This announcement has been prepared by the Company and reviewed by the Company's sponsor, Novus Corporate Finance Pte. Ltd. (the "Sponsor"), in compliance with Rule 226(2)(b) of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made, or reports contained in this announcement.

The contact person for the Sponsor is Mr. Pong Chen Yih, Chief Operating Officer, at 7 Temasek Boulevard, #18-03B Suntec Tower 1, Singapore 038987, telephone [phone].